CRISPR Therapeutics AG ($CRSP)
Filing Information
| Accession Number | 0001193125-26-122274 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 24, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
79,181
Total Value
$148,853.96
P&L
+inf% (+$2,905,079.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel and Secretary | Common Shares | โ | Mar 20, 2026 | Exercise/Conversion | 6,250 | โ | โ | 97,490 | Direct | โ | View Details | |
General Counsel and Secretary | Common Shares | โ | Mar 23, 2026 | Sale | 3,182 | $46.78 | $148,853.96 | 94,308 | Direct | โ | View Details | |
General Counsel and Secretary | Stock Option (Right to Buy) | Derivative | Mar 20, 2026 | Grant/Award | 38,499 | $0.00 | $0.00 | 38,499 | Direct | โ | View Details | |
General Counsel and Secretary | Restricted Stock Units | Derivative | Mar 20, 2026 | Grant/Award | 25,000 | $0.00 | $0.00 | 25,000 | Direct | โ | View Details | |
General Counsel and Secretary | Restricted Stock Units | Derivative | Mar 20, 2026 | Exercise/Conversion | 6,250 | โ | โ | 12,000 | Direct | โ | View Details |